Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 9, 2017

Total Value ($000): $153,841 (100.0% shares, 0.0% debt)

Holdings (11)

— Paratek Pharmaceuticals 32.5%

Value ($000) $50,058 Shares 2,600,410 Est. Cost $34.18 Unrealized —

— Juno Therapeutics 17.7%

Value ($000) $27,283 Shares 1,229,512 Est. Cost $52.22 Unrealized —

— FibroGen 13.0%

Value ($000) $20,028 Shares 812,492 Est. Cost $27.34 Unrealized —

— Egalet 9.6%

Value ($000) $14,739 Shares 2,889,926 Est. Cost $5.98 Unrealized —

— Nabriva Therapeutics 8.9%

Value ($000) $13,751 Shares 1,145,890 Est. Cost $9.50 Unrealized —

— Jounce Therapeutics 8.3%

Value ($000) $12,747 Shares 579,650 Est. Cost $21.99 Unrealized —

— ESSA Pharma 3.4%

Value ($000) $5,295 Shares 1,696,969 Est. Cost $5.22 Unrealized —

— Pieris Pharmaceuticals 2.9%

Value ($000) $4,413 Shares 1,697,384 Est. Cost $1.83 Unrealized —

— Cidara Therapeutics 2.3%

Value ($000) $3,471 Shares 444,965 Est. Cost $10.40 Unrealized —

— CymaBay Therapeutics 0.8%

Value ($000) $1,296 Shares 301,477 Est. Cost $1.94 Unrealized —

— Dicerna Pharmaceuticals 0.5%

Value ($000) $760 Shares 223,457 Est. Cost $16.47 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Paratek Pharmaceuticals	2,600,410	$50,058	32.5%	$34.18	—	Common Stock	699374302
—	Juno Therapeutics	1,229,512	$27,283	17.7%	$52.22	—	Common Stock	48205A109
—	FibroGen	812,492	$20,028	13.0%	$27.34	—	Common Stock	31572Q808
—	Egalet	2,889,926	$14,739	9.6%	$5.98	—	Common Stock	28226B104
—	Nabriva Therapeutics	1,145,890	$13,751	8.9%	$9.50	—	Sponsored ADR	62957M104
—	Jounce Therapeutics	579,650	$12,747	8.3%	$21.99	—	Common Stock	481116101
—	ESSA Pharma	1,696,969	$5,295	3.4%	$5.22	—	Common Stock	29668H104
—	Pieris Pharmaceuticals	1,697,384	$4,413	2.9%	$1.83	—	Common Stock	720795103
—	Cidara Therapeutics	444,965	$3,471	2.3%	$10.40	—	Common Stock	171757107
—	CymaBay Therapeutics	301,477	$1,296	0.8%	$1.94	—	Common Stock	23257D103
—	Dicerna Pharmaceuticals	223,457	$760	0.5%	$16.47	—	Common Stock	253031108